Market LIVE
Published markets; coverage varies by country
Product profile · United States

JADENU

 ·  Patent Litigation & Settlement History ↓

IngredientDEFERASIROX
Application typeNDA
Application206910
Product001
Dosage formTABLET
RouteORAL
Strength90MG
Approval date2015-03-30
Marketing statusPrescription
Status event—
ApplicantNOVARTIS PHARMS CORP
Product source

Current GenericRadar decision

Year2019
SelectionEXISTING_GENERIC
ReviewDISQUALIFIED
Anchor typeFINAL_ANDA
Anchor date2019-11-20
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA2019-11-20
Status event—

Exact product/strength Final ANDA confirmed. Date is earliest verified official product approval for the batch. AG and tentative excluded. Approval date is not commercial launch date. No DS classification asserted.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
92832092034-11-21DS/DP ————
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
210945 / 001FINAL_APPROVAL · FINAL_APPROVED2019-11-20—MSN LABORATORIES PRIVATE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211383 / 001FINAL_APPROVAL · FINAL_APPROVED2019-11-20—ZYDUS PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211824 / 001FINAL_APPROVAL · FINAL_APPROVED2019-11-20—ALEMBIC PHARMACEUTICALS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
209223 / 001FINAL_APPROVAL · FINAL_APPROVED2019-11-25—TEVA PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
208697 / 001FINAL_APPROVAL · FINAL_APPROVED2019-12-13—ACTAVIS ELIZABETH LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210727 / 001FINAL_APPROVAL · FINAL_APPROVED2019-12-27—JEROME STEVENS PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212995 / 001FINAL_APPROVAL · FINAL_APPROVED2019-12-30—PIRAMAL HEALTHCARE UK LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211641 / 001FINAL_APPROVAL · FINAL_APPROVED2020-01-02—SUN PHARMACEUTICAL INDUSTRIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211852 / 001FINAL_APPROVAL · FINAL_APPROVED2020-02-11—CIPLA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
210555 / 001FINAL_APPROVAL · FINAL_APPROVED2020-03-30—ALKEM LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
214341 / 001FINAL_APPROVAL · FINAL_APPROVED2021-05-14—ANNORA PHARMA PRIVATE LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212669 / 001FINAL_APPROVAL · FINAL_APPROVED2021-05-27—CHARTWELL RX SCIENCES LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
214474 / 001FINAL_APPROVAL · FINAL_APPROVED2023-10-16—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211395 / 001FINAL_APPROVAL · FINAL_APPROVED2024-03-22—PHARMOBEDIENT CONSULTING LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211660 / 001FINAL_APPROVAL · FINAL_APPROVED2025-04-11—JUBILANT GENERICS LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 15 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
210945 / 001MSN LABORATORIES PRIVATE LTDFINAL_APPROVAL · FINAL_APPROVED2019-11-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211383 / 001ZYDUS PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2019-11-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211824 / 001ALEMBIC PHARMACEUTICALS LTDFINAL_APPROVAL · FINAL_APPROVED2019-11-20 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
209223 / 001TEVA PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2019-11-25 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
208697 / 001ACTAVIS ELIZABETH LLCFINAL_APPROVAL · FINAL_APPROVED2019-12-13 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210727 / 001JEROME STEVENS PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2019-12-27 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212995 / 001PIRAMAL HEALTHCARE UK LTDFINAL_APPROVAL · FINAL_APPROVED2019-12-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211641 / 001SUN PHARMACEUTICAL INDUSTRIES LTDFINAL_APPROVAL · FINAL_APPROVED2020-01-02 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211852 / 001CIPLA LTDFINAL_APPROVAL · FINAL_APPROVED2020-02-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
210555 / 001ALKEM LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2020-03-30 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
214341 / 001ANNORA PHARMA PRIVATE LTDFINAL_APPROVAL · FINAL_APPROVED2021-05-14 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212669 / 001CHARTWELL RX SCIENCES LLCFINAL_APPROVAL · FINAL_APPROVED2021-05-27 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
214474 / 001AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2023-10-16 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211395 / 001PHARMOBEDIENT CONSULTING LLCFINAL_APPROVAL · FINAL_APPROVED2024-03-22 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211660 / 001JUBILANT GENERICS LTDFINAL_APPROVAL · FINAL_APPROVED2025-04-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
GENERIC2019-11-20TERMINAL_GENERIC_BASISExact product/strength Final ANDA confirmed. Date is earliest verified official product approval for the batch. AG and tentative excluded. Approval date is not commercial launch date. No DS classification asserted.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.